Pega Honors Partners at PegaWorld 2025 for Driving Innovation and Transformation
Pegasystems collaborates with a global ecosystem of best-in-class partners who accelerate our clients' journey to the autonomous enterprise using GenAI. These partners provide services and solutions to address significant challenges faced by leading organizations worldwide, leveraging their deep experience and industry best practices to enhance Pega's world-class solutions and enable industry-leading business outcomes.
The awards are presented in three categories: Partner Achievement, Pega Offering Impact and Industry Excellence Awards. Partners are recognized for their differentiated solutions using Pega.
This year's recipients are as follows:
Partner Achievement Awards
Partner of the Year
Cognizant for overall excellence and achievements in end-to-end transformation across enterprises worldwide with a focus on delivery excellence, innovation, and client success.
Market Maker
Accenture for investing and growing their Pega business with innovative use cases, expanded specializations, and significant Pega practice investment in skills.
Delivery Excellence
EY for its exceptional commitment to continuous learning, ensuring teams remain at the forefront of technological innovation, equipped with the latest knowledge to deliver maximum value to clients.
Innovation Award
TCS for its exceptional commitment to solution development, integration capabilities, and customer satisfaction – and for distinguishing itself through visionary adoption of Pega Blueprint™.
Pega Offering Impact Awards
Customer Decision Hub
Merkle for demonstrating exceptional capabilities in delivering personalized, contextual, and relevant experiences to customers.
Customer Service
Maantic for demonstrating exceptional and innovative capabilities in delivering Pega's customer service offering to our mutual clients.
Workflow Automation
LTIMindtree for demonstrating exceptional capabilities in delivering end-to-end automation solutions that achieved significant business outcomes by optimizing business processes, enhancing customer experiences, and driving operational efficiency.
Industry Excellence Awards
Communications
TCS for the digital transformation and estate modernization of a multitude of communications clients who needed to upgrade their legacy systems with intelligent, customer-centric, and flexible infrastructure.
Financial Services
Accenture for the implementation of an innovative solution to improve customer experience and increase operational efficiency.
Insurance
Capgemini for modernizing a client's underwriting landscape, enhancing the user experience, offering flexibility, and ensuring scalability for future needs.
Government and Public Sector
Aaseya for implementing a prestigious and strategic project to manage all the client's interactions with beneficiaries via portal, mashups, and mobile applications.
Healthcare and Lifesciences
Infosys for partnering with a large US healthcare payer to digitally transform its legacy applications into a single, automated system on Pega, resulting in the right care for patients in less time.
Manufacturing and Transportation
Tech Mahindra for collaboration with an international motor company to launch a flexible and periodic maintenance plan, using real-time vehicle operational data to re-evaluate plans at each service.
The partner awards were announced during the annual PegaWorld® conference at the MGM Grand held in Las Vegas this week through June 3. The conference brings together industry experts and leaders to help attendees reimagine their technology strategies so they can practically and responsibly turbocharge productivity, unleash innovation, and optimize customer interactions. For more information, please visit: http://www.pegaworld.com/.
Quotes & Commentary:
"The success of our clients' digital transformation journeys is fundamentally linked to our partner network," said Daniel Österberg-Holm, vice president of the global partner ecosystem, Pega. "This year's Pega Partner Award recipients have demonstrated exceptional ability to help organizations unlock the full potential of their technology investments and drive meaningful business outcomes."
About Pegasystems
Pega is The Enterprise Transformation Company that helps organizations Build for Change® with enterprise AI decisioning and workflow automation. Many of the world's most influential businesses rely on our platform to solve their most pressing challenges, from personalizing engagement to automating service to streamlining operations. Since 1983, we've built our scalable and flexible architecture to help enterprises meet today's customer demands while continuously transforming for tomorrow. For more information on Pega (NASDAQ: PEGA), visit www.pega.com
All trademarks are the property of their respective owners.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
1 Underrated Reason to Buy This Unstoppable Stock
Key Points Netflix is starting to use artificial intelligence (AI) to improve its business in various ways. These efforts could pay rich benefits down the road. Though there are many other reasons to buy the stock, investors shouldn't forget this one. 10 stocks we like better than Netflix › Netflix (NASDAQ: NFLX) has found its groove. Although the streaming specialist faced some headwinds several years ago that caused its stock price to decline, the company has since recovered and is performing exceptionally well. Netflix's latest quarterly update was yet another smashing success. The bulls might rightly point to the company's strong results as a reason to buy the stock, or the company's dominance in the large and growing streaming industry. All those are, indeed, solid arguments in favor of Netflix, but there is one that investors shouldn't overlook: Netflix's approach to the artificial intelligence (AI) revolution. There is more than one way to leverage AI Generative AI is a powerful technology. Although everyone is familiar with chatbots like ChatGPT, which are primarily geared toward answering queries and generating text, some applications can also be used to create pictures and even videos, doing so relatively quickly and at a low cost. Part of Netflix's strategy is to create content that its users will love watching. It could be tempting for a company in this position to utilize GenAI to produce inexpensive content. There have been similar strategies in other industries. Some companies have fired their employees, thinking that AI would replace them, only to hire many of these same workers back. Netflix's approach to using GenAI in its content creation will be a careful one, according to management. Consider what Netflix co-CEO Ted Sarandos said about creators using GenAI during the company's second-quarter earnings call transcript: "Our creators are already seeing the benefits in production through pre-visualization and shot planning work and, certainly, visual effects. It used to be that only big-budget projects would have access to advanced visual effects like de-aging." So, GenAI is not fundamentally changing the way Netflix makes content. The company is utilizing it as a tool to help improve the process. The approach could yield results in the long run Here's why the company's strategy in using AI is sound. The quality of Netflix's creations is central to its success. The company has made a living by producing shows that generate excitement, discussions, and debates, and spread through word of mouth. Eventually, these attract more subscribers to its platform, and the more subs it has, the more data it can analyze on viewer preferences to help guide its content production strategy. Now, thanks to AI, Netflix will be able to supercharge this strategy. The company isn't interested in cheap content. What it wants is better content. AI can make previously prohibitively expensive special effects more attainable, while also streamlining the pre-production and production process, thereby improving the quality of movies and shows made with the same budget. That means more high-quality content, and, potentially, more engagement (in terms of viewing hours) and more subscribers. This could then lead to higher revenue from subscriptions and advertisements, as well as increased profits. All that won't happen overnight. But if Netflix's approach to using AI in its content production works as intended, the company will meaningfully benefit over the long run. And there is at least one more way in which it plans on using AI. Netflix is currently testing ways for its users to search for movies and shows they enjoy by communicating directly with its interface in a natural, conversational tone, similar to how customers interact with virtual assistants. These initiatives aim to help users find content they enjoy more easily, ultimately increasing engagement. Some tech companies have achieved massive success in using AI-powered algorithms to drive increased engagement on their platforms. That could also happen to Netflix. Netflix is a great long-term bet Netflix is looking at a massive worldwide opportunity in streaming. It continues to wrestle viewing hours away from cable, but there is still plenty of whitespace left. In the U.S., one of the most penetrated streaming markets, streaming accounted for 46% of television viewing time in June. Netflix's growth has helped spur the industry, but the global landscape remains underpenetrated. That's a great reason to invest in Netflix's stock. The company's financial results, combined with its moat stemming from the network effect and a strong brand name, are additional solid arguments. However, investors shouldn't forget about the positive impact AI could have on Netflix's business. Netflix may not be a leader in AI, generating billions in revenue thanks to the technology, but the company's AI strategy looks promising and could significantly improve its business over the long run. Netflix would be a buy even if the market was not in the midst of an AI revolution. The fact that it is, and that Netflix plans to profit from AI advances, makes the stock even more attractive. Should you invest $1,000 in Netflix right now? Before you buy stock in Netflix, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Netflix wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Netflix. The Motley Fool has a disclosure policy. 1 Underrated Reason to Buy This Unstoppable Stock was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
15 hours ago
- Business Upturn
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE:HIMS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Hims securities between April 29, 2025 and June 23, 2025, both dates inclusive (the 'Class Period'). Investors have until August 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) that Hims was engaged in the 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;' (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Additionally, the Complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ('Novo') would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products under the 'personalization' exception; (3) branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform, thereby expanding user choice; and (4) Defendants made positive statements abou the Novo partnership and Hims users' ongoing access to Wegovy alongside compounded semaglutide products. If you purchased or otherwise acquired Hims & Hers shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Yahoo
17 hours ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio
